ICON plc Acquires PRA Health Sciences in $12 Billion Deal

Isracann Biosciences to Acquire Praesidio Health

February 23, 2022

Biotechnology

Isracann Biosciences Inc. entered into a binding letter of intent to acquire Canadian medical research company Praesidio Health Inc. under a stock transaction valued at approximately CAD 4.0 million. Praesidio develops and validates evidence-based natural health medicines (including formulations with cannabinoids and/or psilocybin) for conditions such as urological disorders, anxiety/stress, immune support and sleep.

Praesidian Capital Acquires Undisclosed Genetics Business

September 18, 2019

Healthcare Services

Praesidian Capital announced the acquisition of an integrated clinical and laboratory services company operating in genetic medicine, focused on prenatal and preconception testing and hereditary cancer risk assessments. The deal is Praesidian’s first as an independent sponsor and will serve as a platform for national expansion and future add-on acquisitions.

PRA Acquires Island Style Innovations in Hawai‘i

November 25, 2024

Professional Services

PRA, a Chicago-based business events management firm majority owned by EagleTree Capital, has acquired Island Style Innovations, a Hawai‘i-based destination management and events specialist. The Island Style Innovations team will join PRA’s Hawai‘i office and rebrand as PRA to expand the company’s local capabilities and strengthen its presence in the Hawaiian meetings, conventions, and incentive market.

Pratia Acquires Clinical Research Center (CRC)

January 8, 2025

Healthcare Services

Pratia, a Warsaw-based research site network and part of the Humaneva Group, has acquired Clinical Research Center (CRC), the leading clinical trial site network operating in the Czech Republic and Slovakia. The acquisition expands Pratia's geographic footprint into Slovakia, strengthens its presence in the Czech Republic, and adds CRC's site services and home-based care capabilities to support hybrid and decentralized clinical trials.

Phreesia Acquires Insignia Health

December 13, 2021

Healthcare Services

Phreesia, a public healthcare SaaS company based in Raleigh, North Carolina, has acquired Insignia Health, LLC, the exclusive license holder of the Patient Activation Measure (PAM). The deal brings Insignia's patient activation assessment, education and coaching capabilities into Phreesia's patient engagement platform to expand capabilities and scale PAM across Phreesia's provider and payer customers.

Certara Acquires Pinnacle 21

October 4, 2021

Software

Certara, Inc. completed the acquisition of Pinnacle 21, a provider of SaaS solutions for clinical data standardization, validation and regulatory-submission readiness. Equity holders of Pinnacle 21 received approximately $250 million in cash and 2,239,717 restricted shares of Certara common stock; Certara said the deal expands its data-sciences and software capabilities and is expected to be accretive to revenue and adjusted EBITDA.